RPL4P5: A Protein Implicated in Visual Processing and Cancer Development

Target Name: RPL4P5

NCBI ID: G158345

RPL4P5

Other Name(s): RPL4_3_960 | ribosomal protein L4 pseudogene 5 | Ribosomal protein L4 pseudogene 5

RPL4P5: A Protein Implicated in Visual Processing and Cancer Development

RPL4P5 (RPL4_3_960) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is retinal pigment epithelium-specific protein 5, and it is a member of the RPL family of proteins, which are involved in the regulation of photoreceptor signaling in the retina.

One of the unique aspects of RPL4P5 is its expression pattern in the brain. It is highly expressed in the mouse brain, and its levels are closely correlated with the size of the visual cortex. This suggests that RPL4P5 may be involved in the regulation of visual processing and memory.

In addition to its expression in the brain, RPL4P5 has also been shown to play a role in the development and progression of various diseases, including cancer. For example, studies have shown that RPL4P5 is highly expressed in various types of cancer, including breast, ovarian, and prostate cancer. This suggests that it may be a useful biomarker for the diagnosis and treatment of these diseases.

Furthermore, RPL4P5 has also been shown to interact with several other proteins, including the transcription factor NF-kappa-B. This suggests that it may play a role in the regulation of gene expression and signaling pathways that are important for the development and progression of various diseases.

In conclusion, RPL4P5 is a protein that has been shown to be involved in the regulation of various biological processes in the body, including the regulation of photoreceptor signaling in the retina and the development and progression of cancer. Its expression pattern in the brain and its potential as a biomarker make it an attractive target for further research and development as a potential drug.

Protein Name: Ribosomal Protein L4 Pseudogene 5

The "RPL4P5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPL4P5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets